291 related articles for article (PubMed ID: 36465641)
1. Treatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study.
Auchus RJ; Courtillot C; Dobs A; El-Maouche D; Falhammar H; Lacroix A; Farrar M; O'Donoghue C; Anatchkova M; Cutts K; Taylor N; Yonan C; Lamotte M; Touraine P
Front Endocrinol (Lausanne); 2022; 13():1005963. PubMed ID: 36465641
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM; Stepien KM; Krishan A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901
[TBL] [Abstract][Full Text] [Related]
3. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
Jones CM; Mallappa A; Reisch N; Nikolaou N; Krone N; Hughes BA; O'Neil DM; Whitaker MJ; Tomlinson JW; Storbeck KH; Merke DP; Ross RJ; Arlt W
J Clin Endocrinol Metab; 2017 Jun; 102(6):1797-1806. PubMed ID: 27845856
[TBL] [Abstract][Full Text] [Related]
4. [Long-term morbidity in congenital adrenal hyperplasia].
Tschaidse L; Quitter F; Hübner A; Reisch N
Internist (Berl); 2022 Jan; 63(1):43-50. PubMed ID: 34978615
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia.
Liu SC; Suresh M; Jaber M; Mercado Munoz Y; Sarafoglou K
Front Endocrinol (Lausanne); 2023; 14():1101843. PubMed ID: 36936152
[TBL] [Abstract][Full Text] [Related]
6. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
7. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.
Mallappa A; Sinaii N; Kumar P; Whitaker MJ; Daley LA; Digweed D; Eckland DJ; Van Ryzin C; Nieman LK; Arlt W; Ross RJ; Merke DP
J Clin Endocrinol Metab; 2015 Mar; 100(3):1137-45. PubMed ID: 25494662
[TBL] [Abstract][Full Text] [Related]
8. Challenges in treatment of patients with non-classic congenital adrenal hyperplasia.
Adriaansen BPH; Schröder MAM; Span PN; Sweep FCGJ; van Herwaarden AE; Claahsen-van der Grinten HL
Front Endocrinol (Lausanne); 2022; 13():1064024. PubMed ID: 36578966
[TBL] [Abstract][Full Text] [Related]
9. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature.
Ahmed SEAM; Soliman AT; Ramadan MA; Elawwa A; Abugabal AMS; Emam MHA; De Sanctis V
Acta Biomed; 2019 Sep; 90(3):360-369. PubMed ID: 31580328
[TBL] [Abstract][Full Text] [Related]
10. Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country.
Utari A; Faradz SMH; Ediati A; Rinne T; Ariani MD; Juniarto AZ; Drop SLS; van Herwaarden AE; Claahsen-van der Grinten HL
Front Endocrinol (Lausanne); 2022; 13():1015973. PubMed ID: 36589846
[TBL] [Abstract][Full Text] [Related]
11. Urinary GC-MS steroid metabotyping in treated children with congenital adrenal hyperplasia.
Kamrath C; Hartmann MF; Pons-Kühnemann J; Wudy SA
Metabolism; 2020 Nov; 112():154354. PubMed ID: 32916150
[TBL] [Abstract][Full Text] [Related]
12. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.
Nella AA; Mallappa A; Perritt AF; Gounden V; Kumar P; Sinaii N; Daley LA; Ling A; Liu CY; Soldin SJ; Merke DP
J Clin Endocrinol Metab; 2016 Dec; 101(12):4690-4698. PubMed ID: 27680873
[TBL] [Abstract][Full Text] [Related]
13. Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia.
Kamrath C; Wettstaedt L; Boettcher C; Hartmann MF; Wudy SA
J Steroid Biochem Mol Biol; 2018 Apr; 178():221-228. PubMed ID: 29277706
[TBL] [Abstract][Full Text] [Related]
14. Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Merke DP
J Clin Endocrinol Metab; 2008 Mar; 93(3):653-60. PubMed ID: 18326005
[TBL] [Abstract][Full Text] [Related]
15. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].
Ambroziak U; Bednarczuk T; Ginalska-Malinowska M; Małunowicz EM; Grzechocińska B; Kamiński P; Bablok L; Przedlacki J; Bar-Andziak E
Endokrynol Pol; 2010; 61 Suppl 1():7-21. PubMed ID: 22127631
[TBL] [Abstract][Full Text] [Related]
16. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
Kamrath C; Wettstaedt L; Boettcher C; Hartmann MF; Wudy SA
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):396-406. PubMed ID: 27544322
[TBL] [Abstract][Full Text] [Related]
17. Management challenges and therapeutic advances in congenital adrenal hyperplasia.
Mallappa A; Merke DP
Nat Rev Endocrinol; 2022 Jun; 18(6):337-352. PubMed ID: 35411073
[TBL] [Abstract][Full Text] [Related]
18. Classic congenital adrenal hyperplasia and puberty.
Charmandari E; Brook CG; Hindmarsh PC
Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U77-82. PubMed ID: 15554890
[TBL] [Abstract][Full Text] [Related]
19. Metabotypes of congenital adrenal hyperplasia in infants determined by gas chromatography-mass spectrometry in spot urine.
Kamrath C; Friedrich C; Hartmann MF; Wudy SA
J Steroid Biochem Mol Biol; 2023 Jul; 231():106304. PubMed ID: 36990162
[TBL] [Abstract][Full Text] [Related]
20. [Congenital adrenal hyperplasia].
Stanić M; Nesović M
Med Pregl; 1999; 52(11-12):447-54. PubMed ID: 10748766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
